CANCIDAS
MERCK CANADA INC
Quick answers
Is there a shortage of CANCIDAS in Canada?
No. There is no current shortage of CANCIDAS 70MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
CASPOFUNGIN ACETATE FOR INJECTION
STERIMAX INC
CASPOFUNGIN POWDER FOR INJECTION
TEVA CANADA LIMITED
Other Products
CASPOFUNGIN FOR INJECTION
FRESENIUS KABI CANADA LTD
DIN
02244266
Strength
70MG
Dosage Form
Powder For Solution
Route
Intravenous
Active Ingredient
CASPOFUNGIN (CASPOFUNGIN ACETATE)
See all CASPOFUNGIN (CASPOFUNGIN ACETATE) products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from MERCK CANADA INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
40MG · DIN 00782327
10MG · DIN 02483513
15MG · DIN 02483521
20MG · DIN 02483548
100MG · DIN 02451816
50MG · DIN 02244265
DIN 02549891
DIN 02482592
200MG · DIN 02387174
0.05% · DIN 00688622
0.05% · DIN 00862975
80MG · DIN 02298791